Straits Times Index
3,313.24 -8.84 (-0.27%) Nikkei
39,179.04 +140.88 (+0.36%) Hang Seng
18,028.16 -338.79 (-1.84%) FTSE 100
8,228.48 -16.89 (-0.20%) Bitcoin USD
68,137.07 -1,595.58 (-2.29%) CMC Crypto 200
1,425.59 -21.09 (-1.46%)
VTRS Jan 2025 14.000 call
| Previous close | 0.1500 |
| Open | 0.1500 |
| Bid | 0.1000 |
| Ask | 0.2500 |
| Strike | 14.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.1500 - 0.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 63 |
PR NewswireViatris to Report Second Quarter 2024 Financial Results on August 8, 2024
Viatris Inc. (NASDAQ: VTRS) will report its second quarter 2024 financial results on Thursday, August 8, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
- PR Newswire
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida on Tuesday, June 11, 2024. Chief Executive Officer Scott A Smith and Company executives will represent the company in a fireside chat scheduled at 9:20 a.m. ET.
PR NewswireViatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, Rogerio Vivaldi Coelho, M.D., has been appointed as the newest member of its Board of Directors. Dr. Vivaldi will serve as a member of the recently reestablished Science and Technology Committee of the Board of Directors.
